Compass Therapeutics, Inc.CMPXNASDAQ

Revenue (LTM)

-100.0% YoY

Net Income (LTM)

$-66M

-34.7% YoY

Free Cash Flow

$-49M

Revenue CAGR (5Y)

—

—Marginsstable

FCF($0.0B)

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	0	0	0	1	0
Gross Profit	0	0	0	1	0
Operating Income	-82	-42↑49.1%	-50↓20.9%	-57↓12.4%	-73↓28.6%
Net Income	-82	-39↑52.3%	-42↓8.3%	-49↓16.2%	-66↓34.7%
EBITDA	-80	-40↑50.4%	-48↓21.9%	-55↓13.2%	-73↓32.7%
EPS Diluted	-1.31	-0.35↑73.3%	-0.33↑5.7%	-0.36↓9.1%	-0.42↓16.7%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	145	35↓75.8%	24↓30.7%	43↑79.5%	31↓29.5%
Total Current Assets	147	195↑32.4%	154↓21.0%	133↓13.7%	210↑58.1%
Total Assets	154	200↑29.8%	157↓21.4%	140↓10.5%	220↑56.4%
Total Current Liabilities	11	16↑52.1%	8↓51.8%	9↑13.8%	14↑57.4%
Total Liabilities	14	18↑31.6%	8↓53.7%	15↑82.0%	23↑50.3%
Total Equity	140	182↑29.7%	149↓18.2%	125↓15.7%	197↑57.1%
Total Debt	4	3↓27.3%	2↓41.0%	7↑282.8%	10↑48.2%
Net Debt	-140	-32↑77.2%	-22↑29.7%	-37↓63.8%	-21↑43.5%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-20	-34↓73.5%	-41↓19.0%	-45↓10.4%	-49↓9.6%
Capital Expenditure	-2	-0↑86.5%	-0↑85.8%	-0↓46.7%	-0↑43.2%
Free Cash Flow	-21	-34↓61.7%	-41↓18.4%	-45↓10.5%	-49↓9.5%
Stock-Based Comp	4	5↑32.3%	6↑14.8%	9↑39.9%	8↓2.2%
Net Change in Cash	97	-110↓212.8%	-11↑90.2%	19↑279.7%	-13↓166.7%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance